SG Americas Securities’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-26,448
| Closed | -$159K | – | 3104 |
|
|
2019
Q4 | $159K | Buy |
26,448
+11,818
| +81% | +$71K | ﹤0.01% | 2285 |
|
|
2019
Q3 | $53K | Sell |
14,630
-21,571
| -60% | -$78.1K | ﹤0.01% | 2381 |
|
|
2019
Q2 | $97K | Buy |
+36,201
| New | +$97K | ﹤0.01% | 2423 |
|
|
2019
Q1 | – | Sell |
-46,216
| Closed | -$73K | – | 3064 |
|
|
2018
Q4 | $73K | Buy |
+46,216
| New | +$73K | ﹤0.01% | 2352 |
|
|
2018
Q3 | – | Sell |
-20,490
| Closed | -$58K | – | 3016 |
|
|
2018
Q2 | $58K | Buy |
20,490
+8,388
| +69% | +$23.7K | ﹤0.01% | 2719 |
|
|
2018
Q1 | $45K | Buy |
12,102
+1,035
| +9% | +$3.85K | ﹤0.01% | 2600 |
|
|
2017
Q4 | $32K | Sell |
11,067
-31,162
| -74% | -$90.1K | ﹤0.01% | 2488 |
|
|
2017
Q3 | $190K | Buy |
42,229
+15,800
| +60% | +$71.1K | ﹤0.01% | 2288 |
|
|
2017
Q2 | $121K | Buy |
26,429
+4,144
| +19% | +$19K | ﹤0.01% | 2430 |
|
|
2017
Q1 | $94K | Sell |
22,285
-32,965
| -60% | -$139K | ﹤0.01% | 2665 |
|
|
2016
Q4 | $228K | Buy |
+55,250
| New | +$228K | ﹤0.01% | 1997 |
|
|
2016
Q2 | – | Sell |
-26,422
| Closed | -$204K | – | 2627 |
|
|
2016
Q1 | $204K | Buy |
+26,422
| New | +$204K | ﹤0.01% | 1933 |
|
|
2015
Q3 | – | Sell |
-19,713
| Closed | -$175K | – | 2435 |
|
|
2015
Q2 | $175K | Buy |
19,713
+1,681
| +9% | +$14.9K | ﹤0.01% | 1745 |
|
|
2015
Q1 | $178K | Sell |
18,032
-13,877
| -43% | -$137K | ﹤0.01% | 1687 |
|
|
2014
Q4 | $391K | Sell |
31,909
-9,306
| -23% | -$114K | ﹤0.01% | 1641 |
|
|
2014
Q3 | $411K | Buy |
+41,215
| New | +$411K | ﹤0.01% | 1383 |
|
|
2014
Q2 | – | Sell |
-27,400
| Closed | -$90K | – | 2332 |
|
|
2014
Q1 | $90K | Buy |
+27,400
| New | +$90K | ﹤0.01% | 1957 |
|
|
2013
Q4 | – | Sell |
-18,302
| Closed | -$55K | – | 2668 |
|
|
2013
Q3 | $55K | Buy |
+18,302
| New | +$55K | ﹤0.01% | 2420 |
|